Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
IGIB vs XLV: how they differ
IGIB and XLV hold 0% of their weight in the same names, and XLV returned more over the year.
iShares 5-10 Year Investment Grade Corporate Bond ETF and State Street(R) Health Care Select Sector SPDR(R) ETF.
What they hold in common
By the books each fund has filed, IGIB and XLV hold 0% of their money in the same securities at the same weight.
| Only in IGIB | Only in XLV |
|---|---|
| META PLATFORMS INC 0.24% | Eli Lilly & Co 16.56% |
| AMAZON.COM INC 0.23% | Johnson & Johnson 10.67% |
| ANHEUSER-BUSCH CO/INBEV 0.20% | AbbVie Inc 7.76% |
| BANK OF AMERICA CORP 0.20% | UnitedHealth Group Inc 6.59% |
| BANK OF AMERICA CORP 0.20% | Merck & Co Inc 5.54% |
| BANK OF AMERICA CORP 0.20% | Amgen Inc 3.41% |
| MARS INC 0.19% | Thermo Fisher Scientific Inc 3.25% |
| PFIZER INVESTMENT ENTER 0.19% | Abbott Laboratories 2.76% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026 and May 31, 2026.
| IGIB iShares 5-10 Year Investment Grade Corporate Bond ETF | XLV State Street(R) Health Care Select Sector SPDR(R) ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | iShares | State Street |
| What it is | 5-10 Year Investment Grade Corporate Bond | Health care |
| Total return, 1 year | −1.0% | +20.4% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | −18.5 pts | +2.9 pts |
| Expense ratio | 0.04% | 0.08% |
| Holdings | 2988 | 59 |
IGIB in plain words
IGIB is a bond fund tracking the 5-10 Year Investment Grade Corporate Bond. Over the year to Sep 11, 2026 it returned −1.0% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.04% a year. It sat 3.3% below its high of Feb 27, 2026 on Sep 11, 2026.
XLV in plain words
XLV is an index equity fund tracking the Health care. Over the year to Sep 11, 2026 it returned +20.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Jun 30, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 59 positions, with the top ten at 61.7%. It sat 5.9% below its high of Aug 19, 2026 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, IGIB or XLV?
- In the year to Sep 12, 2026, with distributions reinvested, IGIB returned −1.0% and XLV returned +20.4%, so XLV returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, IGIB or XLV?
- IGIB charges 0.04% a year and XLV charges 0.08%, so IGIB is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, IGIB against XLV, data as of Sep 12, 2026. https://etfiq.com/compare/any/IGIB-XLV Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources